Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/8/2023
Drug R&D and Product Registration News Digest 09/2023 (1)
9/8/2023
Ageing Hong Kong Can Be the Greater Bay Area's Pensions and Healthcare...
9/7/2023
CDE Releases the Annual Report on New Drug Registration Clinical Trial...
9/7/2023
MSD Plans to Boost New Product Launch and Pharma R&D in China
9/6/2023
NMPA Solicits Comments on the Guidelines for the Inspection of Third-P...
9/6/2023
Pfizer Faces Whistleblower Lawsuit over Alleged FCPA Violations in Chi...
9/5/2023
NMPA Issues the Announcement for Applicability of ICH Guidelines S12
9/5/2023
NMPA Issues Announcement for Applicability of ICH Guidelines Q9(R1)
9/4/2023
CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
9/1/2023
SAMR Solicits Public Comments on the Proposed Compliance Guidelines fo...
9/1/2023
CDE Solicits Comments on the Technical Guidelines for Post-Marketing P...
9/1/2023
NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
9/1/2023
Recent Executive Moves
8/31/2023
IQVIA: Chinese Retail Pharmacy Sales up 8.9% in MAT Q2/2023
8/31/2023
NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...
8/31/2023
NHSA to Cancel Hospital Payment Rights for Drug and Consumable Procure...
8/31/2023
MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...
8/31/2023
Recent Official and Executive Moves
8/31/2023
Drug R&D and Product Registration News Digest August 2023 (5)
8/31/2023
Financial-related Company News Digest (August 2023)
8/31/2023
Discussion of Support Issue of Biological Sequence Claims from an Inva...
8/31/2023
China Squeezes Healthcare Swamp with Crackdown and Cost Containment am...
8/30/2023
How to Reduce the Risk of Pharmaceutical Patent Application in China?
8/30/2023
Upcoming Event: 2023 Pharma CI USA Conference & Exhibition
8/30/2023
Upcoming Event: 15th Annual Pharma Market Research Conference
8/30/2023
Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
8/30/2023
CDE Publicizes the List of Reference Formulations for GQCE Studies (73...
8/29/2023
NMPA Announces Package Insert Revision of Two Drug Products
8/29/2023
NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet
8/29/2023
Former Star Official of China's Healthcare Reform and VBP Architect ...
Page:
34
/
718
Total number of articles:
21536
:
[First]
[<<]
[32]
[33]
[34]
[35]
[36]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit